About
10
Publications
1,193
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
2
Citations
Introduction
Skills and Expertise
Publications
Publications (10)
The research aimed to synthesis a product formulation that directly treats ulcerative colitis. • The drug's dose is reduced, and its side effects are minimized. • Mesalamine is a primary treatment for severe and chronic ulcerative colitis, used as an active ingredient. • Guar gum is a novel ingredient that effectively retard the release of drugs fr...
Background: Drug delivery mucoadhesion has been a subject of study for decades, initially focusing on understanding processes and investigating polymers. Mucoadhesive tablets are oral dosage forms that adhere to mucosal surfaces, promoting prolonged contact and localized drug delivery. Aim and Objective: A mucoadhesive tablet formulation of metform...
Oral route of drug administration is typically the initial option for drug administration because it is both practical and affordable. However, major drawback of this route includes the release of drug at a specified place thus reduces the bioavailability. This could be overcome by utilising the gastroretentive drug delivery system (GRRDS). Prolong...
In recent decades, the intricate landscape of mental health challenges has become a focal point of global concern, with particular urgency in Low- and Middle-Income Countries (LMICs). This manuscript delves into the multidimensional tapestry of mental health issues prevalent in these regions, offering an intercontinental analysis that seeks to unra...
Background: Albendazole is a bitter drug and a common antihelmintic drug with a wide range of effects due to its first-pass metabolism and limited bioavailability. It is available in oral dosage form to treat various intestinal illnesses. The goal of this study is to develop a new oral dosage form, a gelatin-based chewable, for pediatrics and devis...
Background: As of 5 August 2022, the ongoing battle against COVID-19 pandemic has resulted 579 million confirmed cases and more than 6.4 million deaths worldwide [1]. With emergence of new variants, the pandemic continues to haunt individuals as well as societies. We expect many new anti-viral treatments in the year three of the pandemic, however,...
BACKGROUND: Around the world, COVID-19 pandemic has exposed vulnerabilities of healthcare systems and whipped out years of progress on poverty alleviation. Nevertheless, the development of multiple COVID-19 vaccines in such a short span of time is truly a triumph of science. World Health Organization (WHO) grades vaccination as "one of the most cos...
